Depression is considered a major public health concern, where existing pharmacological
treatments are not equally effective across all patients. The pathogenesis of depression …

Faecal microbiota transplantation (FMT) is a promising therapy for chronic diseases
associated with gut microbiota alterations. FMT cures 90% of recurrent Clostridioides difficile …

Background & Aims Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder
associated with intestinal dysbiosis. Given the reported promising results of open-label fecal …

Depression is a debilitating disorder, and at least one third of patients do not respond to
therapy. Associations between gut microbiota and depression have been observed in recent …

The human body is home to a variety of micro-organisms. Most of these microbial
communities reside in the gut and are referred to as gut microbiota. Over the last decades …

Intestinal proteases mediate digestion and immune signalling, while increased gut
proteolytic activity disrupts the intestinal barrier and generates visceral hypersensitivity …

Fecal microbiota transplantation (FMT) is highly effective in preventing recurrent
Clostridioides difficile infection (rCDI). However, the mechanisms underpinning its clinical …

Faecal microbiota transplantation (FMT) is an innovative approach to treat diseases that are
associated with gut dysbiosis, by transferring a healthy stool microbiota to a recipient with …

Irritable bowel syndrome (IBS) is a common clinical label for medically unexplained
gastrointestinal symptoms, recently described as a disturbance of the microbiota-gut-brain …

Bacteriophages (hence termed phages) are viruses that target bacteria and have long been
considered as potential future treatments against antibiotic-resistant bacterial infection …